Craig Hallum began coverage on shares of SelectQuote (NYSE:SLQT – Free Report) in a report issued on Monday morning, Marketbeat Ratings reports. The brokerage issued a buy rating and a $4.50 target price on the stock.
SelectQuote Price Performance
SelectQuote stock opened at $2.08 on Monday. The stock has a market capitalization of $351.00 million, a price-to-earnings ratio of -6.48 and a beta of 1.05. The company has a current ratio of 6.84, a quick ratio of 6.84 and a debt-to-equity ratio of 2.01. The stock has a 50 day moving average of $3.13 and a two-hundred day moving average of $2.77. SelectQuote has a twelve month low of $1.03 and a twelve month high of $4.46.
Hedge Funds Weigh In On SelectQuote
A number of large investors have recently bought and sold shares of SLQT. SG Americas Securities LLC increased its stake in shares of SelectQuote by 97.4% during the third quarter. SG Americas Securities LLC now owns 82,848 shares of the company’s stock worth $180,000 after acquiring an additional 40,884 shares during the period. Algert Global LLC boosted its holdings in SelectQuote by 147.1% in the 2nd quarter. Algert Global LLC now owns 50,429 shares of the company’s stock valued at $139,000 after purchasing an additional 30,019 shares in the last quarter. AQR Capital Management LLC increased its position in SelectQuote by 111.7% during the 2nd quarter. AQR Capital Management LLC now owns 88,937 shares of the company’s stock worth $245,000 after purchasing an additional 46,919 shares during the period. Bank of Montreal Can purchased a new position in shares of SelectQuote during the 2nd quarter worth approximately $545,000. Finally, Renaissance Technologies LLC lifted its holdings in shares of SelectQuote by 6.5% in the 2nd quarter. Renaissance Technologies LLC now owns 726,997 shares of the company’s stock valued at $2,007,000 after buying an additional 44,397 shares during the period. Hedge funds and other institutional investors own 34.59% of the company’s stock.
About SelectQuote
SelectQuote, Inc operates a technology-enabled, direct-to-consumer distribution platform that sells a range of insurance products and healthcare services in the United States. The company operates through three segments: Senior; Life; and Auto & Home. It distributes senior health policies, such as medicare advantage, medicare supplement, medicare part D, and other ancillary senior health insurance related products, including prescription drugs, dental, vision, and hearing plans; life insurance products, such as term life, final expense, and other ancillary products, including critical illness, accidental death, and juvenile insurance; homeowners, auto, dwelling fire, and other ancillary insurance products; and non-commercial auto and home property, and casualty policies.
See Also
- Five stocks we like better than SelectQuote
- Investing In Preferred Stock vs. Common Stock
- When Is the Best Time to Invest in Mutual Funds?
- Stock Analyst Ratings and Canadian Analyst Ratings
- Is NVIDIA Stock in a Correction or Consolidation?
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- 3 Oversold Stocks with Big RSI Rebound Potential
Receive News & Ratings for SelectQuote Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SelectQuote and related companies with MarketBeat.com's FREE daily email newsletter.